Vision and Brand Positioning
While AbbVie applies its mission to immediate pipeline governance, its long-term strategic vision is anchored
around establishing a profound, multi-generational global footprint:
"To make a remarkable impact on people's lives, improve our society, and support our communities
through sustainable growth and mission-driven innovation."
This overarching corporate vision steers AbbVie’s long-term enterprise priorities across two primary strategic
vectors:
Sustained Lifecycle Diversification:
Systematically mitigating patent expirations and biosimilar
competition by scaling a robust, diversified development pipeline consisting of roughly 90 compounds,
devices, or active indications across late-stage clinical trials.
Health Equity and Structural Sustainability:
Investing deeply in clinical trial diversity to ensure broad
molecular validity, while executing environmental targets to cut absolute scope 1 and 2 emissions by 42%
by 2030.
Core Corporate Values
To unify its global workforce of over 57,000 specialists and guide its high-stakes bio-ethical decisions, AbbVie
dictates five foundational core values:
Transforming Lives:
Measuring ultimate corporate success through tangible, outcome-first patient impact
and material improvements to a patient's overall quality of life.
Acting with Integrity:
Pursuing the highest global metrics in quality, compliance, and clinical safety,
ensuring absolute transparency from laboratory benches to commercial markets.
Driving Innovation:
Relentlessly investing between 13% to 15% of annual revenues directly back into
discovery research, while maintaining a disciplined, fail-fast laboratory culture.
Embracing Diversity & Inclusion:
Treating all individuals equally with profound dignity and respect,
recognizing that a wide spectrum of backgrounds drives superior scientific problem-solving.
Serving the Community:
Proudly supporting local health infrastructure, civic partnerships, and global
non-profits to create lasting shared value that extends far beyond medicine.
•
•
•
•
•
•
•
AbbVie Inc. Strategic Blueprint
Page 2 of 3
